This is the first meta-analysis comparing the overall survival of patients with limited-stage small cell bladder cancer who underwent radical surgery with platinum-based perioperative chemotherapy vs ...
AstraZeneca's Imfinzi with BCG delivers 32% lower recurrence risk in high-risk bladder cancer. Read more here.
Results presented by AstraZeneca from its phase 3 trial of Imfinzi in patients with high-risk, non-muscle invasive bladder ...
An announcement from Photocure ASA ( ($PHCUF) ) is now available. Photocure ASA has partnered with Intelligent Scopes Corporation to develop AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback